Effects of midazolam on cerebral blood flow in human volunteers
The effects of intravenously administered midazolam on cerebral blood flow were evaluated in eight healthy volunteers using the /sup 133/Xe inhalation technique. Six minutes after an intravenous dose of 0.15 mg/kg midazolam, the cerebral blood flow decreased significantly (P less than 0.001) from a value of 40.6 +/- 3.3 to a value of 27.0 +/- 5.0 ml . 100 g-1 . min-1. Cerebrovascular resistance (CVR) increased from 2.8 +/- 0.2 to 3.9 to 0.6 mmHg/(ml . 100 g-1 . min-1)(P less than 0.001). Mean arterial blood pressure decreased significantly (P less than 0.05) from 117 +/- 8 to 109 +/- 9 mmHg and arterial carbon dioxide tension increased from 33.9 +/- 2.3 to 38.6 +/- 3.2 mmHg (P less than 0.05). Arterial oxygen tension remained stable throughout the study, 484 +/- 95 mmHg before the administration of midazolam and 453 +/- 76 mmHg after. All the subjects slept after the injection of the drug and had anterograde amnesia of 24.5 +/- 5 min. The decrease in mean arterial blood pressure was probably not important since it remained in the physiologic range for cerebral blood flow autoregulation. The increase in arterial carbon dioxide tension observed after the midazolam injection may have partially counteracted the effect of this new benzodiazepine on cerebral blood flow. Our data suggest that midazolam might be a safe agent to use for the induction of anethesia in neurosurgical patients with intracranial hypertension.
- Research Organization:
- Institute of Anesthesiology, University of Geneva, Switzerland
- OSTI ID:
- 6783564
- Journal Information:
- Anesthesiology; (United States), Vol. 56:6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cerebral autoregulation with changes in arterial and cerebral venous pressure
Effect of age on cerebral blood flow during hypothermic cardiopulmonary bypass
Related Subjects
CEREBRUM
BLOOD FLOW
DRUGS
BIOLOGICAL EFFECTS
XENON 133
DIAGNOSTIC USES
ANESTHESIA
BLOOD PRESSURE
HYPERTENSION
INHALATION
PATIENTS
SCINTISCANNING
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
BRAIN
CARDIOVASCULAR DISEASES
CENTRAL NERVOUS SYSTEM
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
EVEN-ODD NUCLEI
INTAKE
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ORGANS
RADIOISOTOPE SCANNING
RADIOISOTOPES
SYMPTOMS
USES
VASCULAR DISEASES
XENON ISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics